July 18, 2025

How a Tiny Gene Ensures the Survival of Male Birds

How a Tiny Gene Ensures the Survival of Male Birds

Researchers from Heidelberg and Edinburgh identify a mechanism that balances the genetic disparity between sex chromosomes

Birds have developed a unique evolutionary solution to ensure the survival of males – a powerful microRNA. This tiny gene allows male embryos to survive despite a genetic imbalance between the sexes by balancing the activity of the sex chromosomes. An international research team led by biologists from Heidelberg University and the University of Edinburgh (Scotland) has discovered this previously unknown mechanism, which differs significantly from the system that mammals have developed in the course of evolution to address the same biological challenge.

Recent studies on the genetic differences between bird sex chromosomes reveal a tiny gene crucial for male survival. | © Nils Trost, Sara Yousefi Taemeh

Sex chromosomes, which determine whether an individual is male or female, originated from an ordinary pair of chromosomes. In mammals, females carry two X chromosomes, while males have one X and one Y chromosome. In contrast, male birds have two Z chromosomes, and female birds have one Z and one W chromosome. Over time, the Y chromosome in mammals and the W in birds lost most of their genes due to their highly specialized sex-specific roles, meaning one sex retains two copies of most genes while the other has only one. Mammals compensate for this genetic imbalance by boosting the activity of the X chromosome in both sexes and “silencing” one of the two X chromosomes in females.

Using chickens as an example, the international research team has now demonstrated how birds resolve this issue. The loss of genetic material on the female-specific W chromosome is offset by increased activity of key genes on the Z chromosome. While this is vital for the survival of female birds, it leads to genetic overactivity in males with two Z chromosomes, resulting in growth defects if left unbalanced. The researchers, led by Prof. Dr Henrik Kaessmann (Heidelberg University) and Dr Mike McGrew (University of Edinburgh), suspected that a previously discovered microRNA – a short regulatory ribonucleic acid – plays a crucial role in this process.

“This microRNA is predominantly active in male birds, which led us to assume that it helps balance the activity of the Z chromosome,” explains Prof. Kaessmann, who conducts research at the Center for Molecular Biology of Heidelberg University (ZMBH). To test their hypothesis, the researchers used gene editing to remove the microRNA and studied the effects during early chicken development. While male embryos could not survive without the microRNA, females developed normally. According to the researchers, the same tiny gene is found in all bird species examined thus far, but not in other animals. “It is the only known microRNA that is essential for the survival of one sex, but not the other,” says Dr Amir Fallahshahroudi, former postdoc in Prof. Kaessmann’s team at the ZMBH and current group leader at Uppsala University in Sweden.

According to Dr McGrew, the mechanism of the male-specific microRNA works like a dimmer switch, dialing down the overactive genes on the two male Z chromosomes. “Our findings show that birds have developed a distinct evolutionary solution to offset the genetic imbalance between sex chromosomes and ensure the survival of male animals,” he emphasizes. They also highlight that evolution can arrive at different solutions for the same biological problem – and that tiny genes can have a dramatic impact on survival. “We now have to ask whether other animal species also use microRNAs to regulate their sex chromosomes, or whether they rely on different systems entirely,” adds Prof. Kaessmann.

Alongside the researchers from Heidelberg, Edinburgh and Uppsala, scientists from Abu Dhabi and China were also involved in the study. This research was funded by various organizations and foundations, including the European Research Council, the NOMIS Foundation, the Swedish Research Council and the Biotechnology and Biological Sciences Research Council (UK). The results have been published in the journal “Nature”.

Original publication

A. Fallahshahroudi, S. Yousefi Taemeh, L. Rodríguez-Montes, N. Trost, D. Frank, P. Lafrenz, J. Koubek, G. Tellez, M. Ballantyne, A. Idoko-Akoh, L. Taylor, A. Sherman, M. Davey, C. Ma, E. Sorato, M. Johnsson, C. Grozou, Y. Xue, L. Liu, G. Kramer, C.-J. Rubin, M. Cardoso-Moreira, M. J. McGrew, H. Kaessmann: A male-essential miRNA is key for avian sex chromosome dosage compensation. Nature (published online 16 July 2025).

DOI: 10.1038/s41586-025-09256-9

Further information

Our latest News

discover more
Workflow Optimisation in the Laboratory: Premiere of the smartLabs Summit in Heidelberg

Workflow Optimisation in the Laboratory: Premiere of the smartLabs Summit in Heidelberg

On September 24, 2025, the smartLabs Summit will open its doors for the first time in Heidelberg – an event dedicated to practical innovation, digitalization, and automation in laboratories. The Summit will take place at BioLabs Heidelberg (Nicola-Tesla Straße 1–3, 69124 Heidelberg) and offers a full program from 1:00 to 7:30 p.m. Initiated by the […]

DFG awards Heidelberg research project on early detection of spinal degeneration nearly €250,000 in funding

DFG awards Heidelberg research project on early detection of spinal degeneration nearly €250,000 in funding

The aim of the project is to use special quantitative MRI to visualize early changes in the intervertebral disc and enable timely treatment. Ultrashort echo time (UTE) MRI opens up completely new approaches to preventive imaging that are difficult or impossible to achieve with conventional MRI methods. Full text in German below. DFG fördert Heidelberger […]

Glioblastoma study shows: Molecular diagnostics could enable targeted therapies without delay

Glioblastoma study shows: Molecular diagnostics could enable targeted therapies without delay

Researchers from Heidelberg University’s Medical Faculty, the German Cancer Research Center (DKFZ), and the National Center for Tumor Diseases (NCT) in Heidelberg have tested the use of targeted drugs in the initial treatment of newly diagnosed glioblastoma, an extremely aggressive brain tumor, in the multicenter study “NCT Neuro Master Match (N2M2)”. Of the five drugs […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp